Latest News & Features
Americas
Alphabet-owned GV has invested in Verve Therapeutics, a cardiovascular company developing gene editing therapies aiming to permanently reduce the risk of coronary artery disease. 14 May 2019
Big Pharma
44 US states have filed a joint complaint against 20 drug companies, alleging they engaged in illegal conspiracies to “manipulate prices, reduce competition” and restrain trade for more than 100 generic drugs. 13 May 2019
Europe
Elkington + Fife has unveiled Mark Scott as a new partner in the UK firm’s patent practice. 13 May 2019
Americas
The Food and Drug Administration has issued final guidance on the pathway for ‘interchangeable’ biosimilar products, in a bid to promote competition in the biologics market. 13 May 2019
Big Pharma
Novartis is set to acquire assets associated with Xiidra ((lifitegrast ophthalmic solution), a dry eye treatment, from Takeda. 10 May 2019
Americas
The US Court of Appeals for the Federal Circuit yesterday, May 8, rejected an appeal from Amgen in patent litigation relating to two Sandoz biosimilars. 9 May 2019
Americas
A generic version of Gilead’s Truvada will hit the market in 2020, a year earlier than expected. 9 May 2019
Biotechnology
Danish pharmaceutical company Lundbeck will acquire Abide Therapeutics, it has been announced. 8 May 2019
Biotechnology
A former scientist at Bayer CropScience shared confidential information with his new employer, which was used to develop commercial biopesticide products, according to a claim filed by the agricultural company. 8 May 2019
Big Pharma
One of Allergan’s patents has been invalidated after it was challenged by UK-based pharmaceutical companies Accord Healthcare and Aspire Pharma. 7 May 2019